Minimum inhibitory concentration and postantibiotic effect of amikacin for equine isolates of methicillin-resistant staphylococcus aureus in vitro

Veterinary Surgery

Volumn 38, Issue 5, 2009, Pages 664-669

  Caron, John P ^a   Bolin, Carole A ^b   Hauptman, Joseph G ^b   Johnston, Kimberly A ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT;

ANIMAL; ARTICLE; DRUG EFFECT; HORSE; HORSE DISEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STAPHYLOCOCCUS INFECTION;

AMIKACIN; ANIMALS; ANTI-BACTERIAL AGENTS; HORSE DISEASES; HORSES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS;

EQUIDAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 67949086759     PISSN: 01613499     EISSN: 1532950X     Source Type: Journal    
DOI: 10.1111/j.1532-950X.2009.00551.x     Document Type: Article

References (26)

1. Berger-Bachi B, Rohrer S: Factors influencing methicillin resistance in staphylococci. Arch Microbiol 178:165-171, 2002
2. Weese JS, Rousseau J, Willey BM, et al: Methicillin-resistant Staphylococcus aureus in horses at a veterinary teaching hospital: frequency, characterization, and association with clinical disease. J Vet Int Med 20:182-186, 2006
3. Weese JS, Lefebvre SL: Risk factors for methicillin-resistant Staphylococcus aureus colonization in horses admitted to a veterinary teaching hospital. Can Vet J 48:921-926, 2007
4. Anderson MEC, Lefebvre SL, Rankin SC, et al: Retrospec-tive multicentre study of methicillin-resistant Staphylococ-cus aureus infections in 115 horses. Equine Vet J 41:401-405, 2009
5. Van den Eede A, Martens A, Lipinska U, et al: High occur-rence of methicillin-resistant Staphylococcus aureus ST398 in equine nasal samples. Vet Microbiol 133:138-144, 2009
6. Trostle SS, Peavey CL, King DS, Hartmann FA: Treatment of methicillin-resistant Staphylococcus epidermidis infection following repair of an ulnar fracture and humeroradial joint luxation in a horse. J Am Vet Med Assoc 218:554-559, 2001
7. Rubio-Martínez LM, López-Sanromán J, Cruz AM, et al: Evaluation of safety and pharmacokinetics of vancomycin after intraosseous regional limb perfusion and comparison of results with those obtained after intravenous regional limb perfusion in horses. Am J Vet Res 67:1701-1707, 2006
8. Moreillon P: New and emerging treatment of Staphylococcus aureus infections in the hospital setting. Clin Microbiol In-fect 14(Suppl 3): 32-41, 2008
9. Rubio-Martinez LM, Cruz AM: Antimicrobial regional limb perfusion in horses. J Am Vet Med Assoc 228:706-717, 2006
10. Mattson S, Bouré L, Pearce S, et al: Intraosseous gentamicin perfusion of the distal metacarpus in standing horses. Vet Surg 33:180-186, 2004
11. Butt TD, Bailey JV, Dowling PM, et al: Comparisons of 2 techniques for regional antibiotic delivery to the equine forelimb: intraosseous perfusion vs. intravenous perfusion. Can Vet J 42:617-622, 2001
12. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard - 7th Ed. CLSI document M7-A7, Clinical and Laboratory Standards Institute, Wayne, PA, 2006
13. McDougal LK, Steward CD, Killgore GE, et al: Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylo-coccus aureus isolated from the United States: establishing a national database. J Clin Microbiol 41:5113-5120, 2003
14. Bundtzen R, Gerber AU, Cohn DL, et al: Postantibiotic suppression of bacterial growth. Rev Infect Dis 3:28-37, 1981
15. Scheuch BC, Van Hoogmoed LM, Wilson WD, et al: Com-parison of intraosseous or intravenous infusion for delivery of amikacin sulfate to the tibiotarsal joint of horses. Am J Vet Res 63:374-380, 2002
16. Performance Standards for Antimicrobial Susceptibility Testing. Sixteenth Informational Supplement Clinical and Laboratory Standards Institute document M100-S17, Clin-ical and Laboratory Standards Institute, Wayne, PA, 2007, p. 113
17. Craig WA, Ebert SC: Killing and regrowth of bacteria in vitro: a review. Scand J Infect Dis 74(Suppl): 63-70, 1991
18. Schlaeffer F, Blaser J, Laxon J, et al: Enhancement of le-ucocyte killing of resistant bacteria selected during expo-sure to aminoglycosides or quinolones. J Antimicrob Chemother 25:941-948, 1990
19. Odenholt-Tornqvist I, Lowdin E, Cars O: Postantibiotic sub-MIC effects of vancomycin, roxithromycin, Sparfloxacin, and amikacin. Antimicrob Agents Chemother 36:1852-1858, 1992
20. Tam VH, Kabbara S, Vo G, et al: Comparative pharmaco-dynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob Agents Chemother 50:2626-2631, 2006
21. Isaksson B, Maller R, Nilsson LE, et al: Postantibiotic effect of aminoglycosides on staphylococci. J Antimicrob Che-mother 32:215-222, 1993
22. Van der Auwera P, Klastersky J: Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin. Antimicrob Agents Chemother 31:1061-1068, 1987
23. Carmen Dominguez M, de la Rosa M, Borobio MV: Application of a spectrophotometric method for the de-termination of post-antibiotic effect and comparison with viable counts in agar. J Antimicrob Chemother 47:391-398, 2001
24. Li RC, Tang MC: Post-antibiotic effect induced by an an-tibiotic combination: influence of altered susceptibility to individual components. J Antimicrob Chemother 55:583-586, 2005
25. Renneberg J, Walder M: Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo. Antimicrob Agents Chemother 33:1714-1720, 1989
26. Gould IM, Milne K, Jason C: Concentration-dependent bac-terial killing, adaptive resistance and post-antibiotic effect of ciprofloxacin alone and in combination with gentamicin. Drugs Exp Clin Res 16:621-628, 1990